Login / Signup
Rita Goreti Amaral
ORCID
Publication Activity (10 Years)
Years Active: 2020-2024
Publications (10 Years): 6
Top Topics
General Practice
Adverse Drug
Electronic Health Record
Meta Analyses
Top Venues
Revista de saude publica
Einstein (Sao Paulo, Brazil)
European journal of clinical pharmacology
Ciencia & saude coletiva
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Lunara Teles Silva
,
Ana Carolina Figueiredo Modesto
,
Rodrigo Alves de Oliveira
,
Rita Goreti Amaral
,
Flavio Marques Lopes
Mortality and years of life lost related to adverse drug events in Brazil.
Revista de saude publica
58 (2024)
Lunara Teles Silva
,
Ana Carolina Figueiredo Modesto
,
Rodrigo Alves de Oliveira
,
Rita Goreti Amaral
,
Flavio Marques Lopes
Mortality and years of life lost related to adverse drug events in Brazil.
Revista de saude publica
58 (2024)
Lunara Teles Silva
,
Ana Carolina Figueiredo Modesto
,
Rodrigo Alves de Oliveira
,
Rita Goreti Amaral
,
Flavio Marques Lopes
Hospitalizations and adverse drug events in the Brazilian unified health system: a ten-year retrospective analysis of routine data.
Revista de saude publica
56 (2022)
Lunara Teles Silva
,
Ana Carolina Figueiredo Modesto
,
Rita Goreti Amaral
,
Flavio Marques Lopes
Hospitalizations and deaths related to adverse drug events worldwide: Systematic review of studies with national coverage.
European journal of clinical pharmacology
(2021)
Amanda Queiroz Soares
,
Miriam Amaral Melo
,
Pedro Ivo da Silva
,
Virgínia Oliveira Chagas
,
Mércia Pandolfo Provin
,
Maisa Miralva da Silva
,
Vanessa Carvalho da Silva Vila
,
Rita Goreti Amaral
"A lack of information keeps us from medicine, well-being, harmony…": a mixed method study with plaintiffs requesting medicines in administrative cases.
Ciencia & saude coletiva
27 (3) (2021)
Eduardo Silva Araújo
,
Ana Carolina Figueiredo Modesto
,
Tatyana Xavier Almeida Matteucci Ferreira
,
Mércia Pandolfo Provin
,
Dione Marçal Lima
,
Rita Goreti Amaral
Pharmaceutical intervention in the rational use of intravenous omeprazole.
Einstein (Sao Paulo, Brazil)
18 (2020)